Alkermes said Nov. 18 that it will acquire Boston-based drugmaker Rodin Therapeutics for $100 million to expand its portfolio of drugs to treat neurodegenerative disorders.

Pharmaceutical Research and Manufacturers of America, the industry's top lobbying group, brought in a record $459 million in revenue in 2018, according to tax returns obtained by OpenSecrets.org.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leaders in the last week.

The FDA approved Nov. 18 Pfizer's drug, Abrilada, a biosimilar to AbbVie's blockbuster rheumatoid arthritis drug, Humira. 

PillPack, the internet pharmacy Amazon acquired in 2018, has rebranded to include "Amazon Pharmacy" in its logo and other paperwork, according to CNBC.

The Federal Trade Commission has cleared the way for Bristol-Myers Squibb to complete its acquisition of Celgene for $74 billion, one of the largest deals in pharmaceutical history.

The FDA approved Nov. 15 Novartis' drug, Adakveo, the first targeted therapy approved to treat sickle cell disease.

Roche will pay $390 million to purchase a small Lexington, Mass.-based drugmaker, Promedior, according to The Boston Globe.

The FDA approved Shionogi & Co.'s drug, Fetroja, an antibiotic designed to treat complicated urinary tract infections.

The FDA approved Nov. 14 BeiGene USA's drug, Brukinsa, designed to treat adult patients with mantle cell lymphoma who have received at least one prior therapy.